ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Valtrate, an iridoid compound in Valeriana, elicits anti-glioblastoma activity through inhibition of the PDGFRA/MEK/ERK signaling pathway

Liu, Xuemeng; Hu, Yaotian; Xue, Zhiyi; Zhang, Xun; Liu, Xiaofei; Liu, Guowei; Wen, Muzi; Chen, Anjing; Huang, Bin; Li, Xingang; Yang, Ning*; Wang, Jian*南方医科大学; 山东大学
Journal of Translational Medicine2023-2-24DOI: 10.1186/s12967-023-03984-0
2被引4阅读
引用收藏
分享

摘要

BackgroundValtrate, a natural compound isolated from the root of Valeriana, exhibits antitumor activity in many cancers through different mechanisms. However, its efficacy for the treatment of glioblastoma (GBM), a tumor type with a poor prognosis, has not yet been rigorously investigated.MethodsGBM cell lines were treated with valtrate and CCK-8, colony formation and EdU assays, flow cytometry, and transwell, 3D tumor spheroid invasion and GBM-brain organoid co-culture invasion assays were performed to assess properties of proliferation, viability, apoptosis and invasion/migration. RNA sequencing analysis on valtrate-treated cells was performed to identify putative target genes underlying the antitumor activity of the drug in GBM cells. Western blot analysis, immunofluorescence and immunohistochemistry were performed to evaluate protein levels in valtrate-treated cell lines and in samples obtained from orthotopic xenografts. A specific activator of extracellular signal-regulated kinase (ERK) was used to identify the pathways mediating the effect.ResultsValtrate significantly inhibited the proliferation of GBM cells in vitro by inducing mitochondrial apoptosis and suppressed invasion and migration of GBM cells by inhibiting levels of proteins associated with epithelial mesenchymal transition (EMT). RNA sequencing analysis of valtrate-treated GBM cells revealed platelet-derived growth factor receptor A (PDGFRA) as a potential target downregulated by the drug. Analysis of PDGFRA protein and downstream mediators demonstrated that valtrate inhibited PDGFRA/MEK/ERK signaling. Finally, treatment of tumor-bearing nude mice with valtrate led to decreased tumor volume (fivefold difference at day 28) and enhanced survival (day 27 vs day 36, control vs valtrate-treated) relative to controls.ConclusionsTaken together, our study demonstrated that the natural product valtrate elicits antitumor activity in GBM cells through targeting PDGFRA and thus provides a candidate therapeutic compound for the treatment of GBM.

学科与关键词

关键词
ValtrateGlioblastomaMitochondrial apoptosisEpithelial mesenchymal transitionInvasion and migrationPDGFRAMEKERK signaling pathway
相关
加载中…
  • Chelerythrine inhibits the progression of glioblastoma by suppressing the TGFB1-ERK1/2/Smad2/3-Snail/ZEB1 signaling pathway
    Zhu, Mingwei; Niu, Jiamei; Jiang, Jian; Dong, Tianxiu; Chen, Yaodong; Yang, Xiuhua*; Liu, Pengfei*Life Sciences, 2022, 293: 120358.被引 6
  • CCL2-targeted ginkgolic acid exerts anti-glioblastoma effects by inhibiting the JAK3-STAT1/PI3K-AKT signaling pathway
    Chen, Xi; Zhu, Mingwei; Zou, Xiaomeng; Mao, Yingxuan; Niu, Jiamei; Jiang, Jian; Dong, Tianxiu; Shi, Ying; Yang, Xiuhua*; Liu, Pengfei*Life Sciences, 2022, 311: 121174.被引 2
  • Construction of IL-13 Receptor α2-Targeting Resveratrol Nanoparticles against Glioblastoma Cells: Therapeutic Efficacy and Molecular Effects
    Lin, Xiao-Min; Shi, Xiao-Xiao; Xiong, Le; Nie, Jun-Hua; Ye, Hai-Shan; Du, Jin-Zi; Liu, Jia*INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22(19): 10622.被引 6
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Translational Medicine
发表日期
2023-02-24
卷期
第 21 卷, 第 1 期
页码
147
DOI
10.1186/s12967-023-03984-0
语言
ENGLISH
成果收录
SCIE
资助标注
University of Bergen; National Natural Science Foundation of China [81972351]; "20 Articles of Higher Education" Funding Project Independent Training Innovation Team of Jinan [2019GXRC006]; Central Guide Local Science and Technology Development Special Funds Projects [YDZX2021010]; Special Foundation for Taishan Scholars [tshw201502056, tsqn201909173]; Department of Science & Technology of Shandong Province [ZR2019ZD33, 2020CXGC010903]; Clinical Research Center of Shandong University [2020SDUCRCB002]; Research Project of Jinan Microecological Bio-medicine Shandong Laboratory [JNL-2022042C, JNL-2022003A]

作者

  • L

    Liu, Xuemeng (第一作者)

    shandong univ

  • H

    Hu, Yaotian

    shandong univ

查看全部 12 位作者收起作者
  • X

    Xue, Zhiyi

    shandong univ

  • Z

    Zhang, Xun

    shandong univ

  • L

    Liu, Xiaofei

    shandong univ

  • L

    Liu, Guowei

    shandong univ

  • W

    Wen, Muzi

    southern med univ

  • C

    Chen, Anjing

    shandong univ

  • H

    Huang, Bin

    shandong univ

  • L

    Li, Xingang

    shandong univ

  • Y

    Yang, Ning (通讯)

    shandong univ

  • W

    Wang, Jian (通讯)

    shandong univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417